AU2019389762B2 - Anti-viral compositions - Google Patents

Anti-viral compositions

Info

Publication number
AU2019389762B2
AU2019389762B2 AU2019389762A AU2019389762A AU2019389762B2 AU 2019389762 B2 AU2019389762 B2 AU 2019389762B2 AU 2019389762 A AU2019389762 A AU 2019389762A AU 2019389762 A AU2019389762 A AU 2019389762A AU 2019389762 B2 AU2019389762 B2 AU 2019389762B2
Authority
AU
Australia
Prior art keywords
oil
lip balm
butter
wax
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019389762A
Other languages
English (en)
Other versions
AU2019389762A1 (en
Inventor
Daniel Calladine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calladine Pharmaceuticals Ltd
Original Assignee
Calladine Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calladine Pharmaceuticals Ltd filed Critical Calladine Pharmaceuticals Ltd
Publication of AU2019389762A1 publication Critical patent/AU2019389762A1/en
Application granted granted Critical
Publication of AU2019389762B2 publication Critical patent/AU2019389762B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2019389762A 2018-11-29 2019-11-28 Anti-viral compositions Active AU2019389762B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1819418.3 2018-11-29
GBGB1819418.3A GB201819418D0 (en) 2018-11-29 2018-11-29 Anti-viral compositions
PCT/EP2019/082850 WO2020109442A1 (en) 2018-11-29 2019-11-28 Anti-viral compositions

Publications (2)

Publication Number Publication Date
AU2019389762A1 AU2019389762A1 (en) 2021-07-01
AU2019389762B2 true AU2019389762B2 (en) 2025-07-31

Family

ID=65024906

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019389762A Active AU2019389762B2 (en) 2018-11-29 2019-11-28 Anti-viral compositions

Country Status (8)

Country Link
US (1) US12295956B2 (https=)
EP (1) EP3886861B1 (https=)
JP (1) JP2022509240A (https=)
AU (1) AU2019389762B2 (https=)
CA (1) CA3121051A1 (https=)
ES (1) ES3035188T3 (https=)
GB (1) GB201819418D0 (https=)
WO (1) WO2020109442A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240350570A1 (en) * 2023-04-19 2024-10-24 Daniel Tyler WHITING Topical skin care preparation comprising ephedra viridis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948332A1 (en) * 1996-10-31 1999-10-13 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
RU2282473C2 (ru) * 2002-02-04 2006-08-27 Закрытое акционерное общество "Эвалар" Лечебно-профилактическая помада с противовирусной активностью и способ ее приготовления
BE1022817B1 (nl) * 2015-08-25 2016-09-13 Stasisport Pharma Nv Antivirale samenstelling en lippenstift omvattende genoemde samenstelling

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
LU85083A1 (fr) * 1983-11-09 1985-07-17 Oreal Composition cosmetique ou pharmaceutique sous forme d'un baton ou stick constitue de deux phases grasses concentriques,son procede de preparation et etui en permettant sa conservation et sa distribution
DK169121B1 (da) 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
RU2093140C1 (ru) 1995-03-09 1997-10-20 Товарищество с ограниченной ответственностью "Снежный Барс" Лечебно-профилактическая помада и способ ее приготовления
AU2036297A (en) 1996-03-20 1997-10-10 Glaxo Group Limited Topical formulations of aciclovir
FR2773032B1 (fr) 1997-12-22 2001-12-21 Nortel Matra Cellular Modulation d'un signal numerique a spectre etroit et a enveloppe sensiblement constante
ITMI981528A1 (it) 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
JP2003128521A (ja) * 2001-10-16 2003-05-08 Rohto Pharmaceut Co Ltd 外用製剤
US8697712B2 (en) 2004-04-05 2014-04-15 Laboratorios Liomont, S.A. De C.V. Presentation of an antiviral pharmaceutical composition
US20080031979A1 (en) * 2006-08-04 2008-02-07 Claude Saliou Use of extracts for the treatment of viral disorders
US7695727B2 (en) * 2006-10-11 2010-04-13 Wyeth Llc Botanical butter stick lip balm
US8333955B2 (en) 2007-03-19 2012-12-18 Elc Management Llc High shine, stick-shaped cosmetic products
EP1977729B1 (en) * 2007-04-05 2010-03-03 Eckart GmbH Cosmetic compositions containing pearlescent pigments
CN100562631C (zh) 2007-04-05 2009-11-25 崔文瀛 球网壳组合结构
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
WO2013077881A1 (en) 2011-11-23 2013-05-30 3B Pharmaceuticals, Inc. Antiviral formulations
US8722106B2 (en) * 2011-12-02 2014-05-13 The MotherVine Nutraceuticals Co. LLC Lip balm composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948332A1 (en) * 1996-10-31 1999-10-13 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
RU2282473C2 (ru) * 2002-02-04 2006-08-27 Закрытое акционерное общество "Эвалар" Лечебно-профилактическая помада с противовирусной активностью и способ ее приготовления
BE1022817B1 (nl) * 2015-08-25 2016-09-13 Stasisport Pharma Nv Antivirale samenstelling en lippenstift omvattende genoemde samenstelling

Also Published As

Publication number Publication date
CA3121051A1 (en) 2020-06-04
EP3886861A1 (en) 2021-10-06
EP3886861B1 (en) 2025-05-07
US12295956B2 (en) 2025-05-13
ES3035188T3 (en) 2025-08-29
US20220016124A1 (en) 2022-01-20
GB201819418D0 (en) 2019-01-16
EP3886861C0 (en) 2025-05-07
WO2020109442A1 (en) 2020-06-04
AU2019389762A1 (en) 2021-07-01
JP2022509240A (ja) 2022-01-20

Similar Documents

Publication Publication Date Title
Sahu et al. Skin cream as topical drug delivery system: a review
KR101769010B1 (ko) Trpv1 선택적 작용제를 포함하는 통증 완화 조성물, 및 이의 제조방법 및 용도
ES2605405T3 (es) Composiciones que contienen agentes antiacné y su uso
JP2003528821A (ja) 局所適用のための薬学的および化粧用の担体または組成物
US12582615B2 (en) Topical analgesic gel compositions
US9439917B1 (en) Anti-blepharitis compositions and their use
US10736836B2 (en) Method of treating external tissues with waxes
AU2019389762B2 (en) Anti-viral compositions
Yadav et al. Pharmaceutical preparation and evaluation of cold cream
US10238596B1 (en) Restorative formulations
CA2518329C (en) Rapidly absorbing lipophilic skin compositions and uses therefor
Urooj et al. Formulation and Evaluation of Neem Infused Anti-Acne Cream
JP2022509240A5 (https=)
JP6484251B2 (ja) ミツバチ生成物を含む組成物
Sahu et al. Journal of Pharmaceutical and Biological Sciences
US6649194B2 (en) Topical analgesics and methods of use
US20190282537A1 (en) Pharmaceutical composition for treating skin ulcers, injuries and burns

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)